Oruka Therapeutics, Inc. ORKA Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by Oruka Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The official record: Oruka Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Oruka Therapeutics, Inc.'s total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Oruka Therapeutics, Inc.'s total equity?
- Oruka Therapeutics, Inc. (ORKA) reported total equity of $486.72M in Q1 2026.
- How has Oruka Therapeutics, Inc.'s total equity changed year-over-year?
- Oruka Therapeutics, Inc.'s total equity increased by 33.4% year-over-year, from $364.73M to $486.72M.
- What is the long-term trend for Oruka Therapeutics, Inc.'s total equity?
- Over 5 years (2020 to 2025), Oruka Therapeutics, Inc.'s total equity has grown at a 58.9% compound annual growth rate (CAGR), from $46.52M to $471.93M.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.